EUVIMEDEUVIMED entdecken
Crossref

Tuber Lectin Extracted from Xanthosoma violaceum (XVL) Promotes Apoptosis and Suppresses Proliferation in A549 Lung Adenocarcinoma Cells

G T Ramya, E Sarathkumar, M Meghana, N Anitha, S J Prashanth, G J Sathisha

AJ Journal of Medical Sciences · 31.12.2025 · 2 (4) · 177-184

DOI: 10.71325/ajjms.v2i4.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AJ Journal of Medical Sciences, online erschienen am 31.12.2025. Verfasst von G T Ramya und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer accounts for major cancer related mortality worldwide. Among the subtypes, non-small cell lung cancer (NSCLC) considered to be the most prevalent subtype. Due inferiority of current treatment strategies such as toxicity, non-selectivity, high cost and resistance emphasizes the exploration for selective and safer anticancer agents. In view of their recognition of aberrant carbohydrate ligands on the cancer cell surface, various plant lectins including Xanthosoma violaceum lectin (XVL) exhibit antiproliferative and apoptosis-inducing activities. Despite this, its effects on lung cancer cells remain insufficiently investigated.

Methods

Xanthosoma violaceum lectin (XVL), which was previously purified and characterized, was used to investigate for antiproliferative activity against human lung adenocarcinoma A549 cells and normal embryonic kidney cells (HEK293) were used as control. MTT assay, an in vitro assay, has been employed to check the cell viability. Varying concentrations of XVL (0.3110 µg100 µL) was used to treat the cells. Prolonged cytotoxicity and cell migration were investigated by clonogenic and wound healing assays respectively. The caspase-3, -8, and -9 activity, flow cytometry, and comet assays were adapted to induction of apoptosis, cell cycle arrest and DNA fragmentation respectively.

Results

The cell viability of A549 was significantly reduced by XVL in a dose-dependent manner with an IC₅₀ of 6.508 µg100 µL. However, it exhibits minimal toxicity toward HEK293 cells. Colony formation and cell migration were markedly inhibited. G₂M phase cell cycle arrest along with a moderate increase in Sub G₀G₁ apoptotic cell populations were observed from the Flow cytometric data. DNA fragmentation and production of caspase-3, -8, and -9 upon treatment with XVL induces apoptosis with the involvement of both intrinsic and extrinsic apoptotic pathways.

Conclusion

Overall, Xanthosoma violaceum lectin specifically retards proliferation, migration, and survival of A549 lung cancer cells with less toxicity to normal cells. The results of present investigation underpin the potential of XVL as a natural anticancer agent and require preclinical investigation.

Zitieren

APA

Ramya, G. T., Sarathkumar, E., Meghana, M., Anitha, N., Prashanth, S. J., & Sathisha, G. J. (2025). Tuber Lectin Extracted from Xanthosoma violaceum (XVL) Promotes Apoptosis and Suppresses Proliferation in A549 Lung Adenocarcinoma Cells. AJ Journal of Medical Sciences, 2(4), 177-184. https://doi.org/10.71325/ajjms.v2i4.1

Vancouver

Ramya GT, Sarathkumar E, Meghana M, Anitha N, Prashanth SJ, Sathisha GJ. Tuber Lectin Extracted from Xanthosoma violaceum (XVL) Promotes Apoptosis and Suppresses Proliferation in A549 Lung Adenocarcinoma Cells. AJ Journal of Medical Sciences. 2025;2(4):177-184. doi:10.71325/ajjms.v2i4.1

BibTeX
@article{Ramya2025,
  author = {Ramya, G T and Sarathkumar, E and Meghana, M and Anitha, N and Prashanth, S J and Sathisha, G J},
  title = {Tuber Lectin Extracted from Xanthosoma violaceum (XVL) Promotes Apoptosis and Suppresses Proliferation in A549 Lung Adenocarcinoma Cells},
  journal = {AJ Journal of Medical Sciences},
  year = {2025},
  volume = {2},
  number = {4},
  pages = {177--184},
  doi = {10.71325/ajjms.v2i4.1}
}
Kostenlos starten →